What the New Research Uncovered
To get a definitive answer, researchers from the Yale School of Public Health and other centers conducted a massive analysis. Unlike previous research, they had access to detailed data from individual patients across more than 130 clinical trials. This allowed for a much clearer picture of the risks. The results were stark: people taking rosiglitazone had a 33% higher likelihood of experiencing a major heart-related event, such as a heart attack, heart failure, or even death from cardiovascular causes, compared to those who didn’t take the drug.
StudyAnatomyTAKING A STATIN OR BLOOD PRESSURE MEDICATION?Your numbers look better. So why do you still feel tired, foggy, or off?
Discover the four overlooked factors your prescriptions were never designed to address—and why they may still affect how you feel.
